Other

Cash and cash equivalents, end of period

Bunge Cash and cash equivalents, end of period decreased by 36.1% to $847.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 73.9%, from $3.25B to $847.00M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2026

How to read this metric

Higher levels indicate strong liquidity and readiness to meet claims, whereas lower levels may signal a need for capital raising or asset liquidation.

Detailed definition

This represents the total liquidity available to the company, including highly liquid assets and cash that may be subjec...

Peer comparison

Insurance companies typically maintain high levels of cash and equivalents to satisfy regulatory liquidity requirements.

Metric ID: other_cash_cash_equivalents_restricted_cash_and_restrict_5675e1

Historical Data

10 periods
 Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$3.06B$1.36B$2.19B$2.95B$1.20B$2.89B$3.25B$6.81B$1.33B$847.00M
QoQ Change-55.5%+61.3%+34.7%-59.3%+140.5%+12.5%+109.7%-80.5%-36.1%
YoY Change-3.4%-11.7%+31.7%+10.0%+467.2%-54.1%-73.9%
Range$847.00M$6.81B
CAGR-43.5%
Avg YoY Growth+52.3%
Median YoY Growth-3.4%
Current Streak2 quarters decline

Frequently Asked Questions

What is Bunge's cash and cash equivalents, end of period?
Bunge (BG) reported cash and cash equivalents, end of period of $847.00M in Q1 2026.
How has Bunge's cash and cash equivalents, end of period changed year-over-year?
Bunge's cash and cash equivalents, end of period decreased by 73.9% year-over-year, from $3.25B to $847.00M.
What does cash and cash equivalents, end of period mean?
The total amount of cash and highly liquid assets held by the company, including restricted funds.